DS-1103a Combination Therapy First-in-human (FIH) Study

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503965-48-00

Acronym

DS1103-074

Enrollment

Registered

2023-10-05

Start date

2024-01-11

Completion date

Unknown

Last updated

2025-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced (unresectable or metastatic) human epidermal growth receptor 2 (HER2)-expressing/HER2-mutated solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026